Zimmer Biomet Announces Changes To Company’s Board Of Directors
February 24, 2021 at 11:09 p.m.
By Staff Report-
Those changes include:
• Sreelakshmi Kolli, senior vice president, chief digital officer of Align Technology Inc., has been appointed as a member of the board of directors, effective immediately.
• Zimmer Biomet Non-Executive Chairman Larry C. Glasscock will retire in May pursuant to the mandatory retirement age in the company's corporate governance guidelines.
• Zimmer Biomet President and CEO Bryan C. Hanson will be appointed as chairman of the board upon Glasscock's retirement.
• Christopher B. Begley will be named lead independent director.
• Gail K. Boudreaux has informed the board that she does not intend to stand for re-election at the upcoming 2021 annual meeting of shareholders.
"The addition of Sree to our board of directors comes at a time when Zimmer Biomet is expanding our portfolio of integrated digital and robotic technologies that leverage data, machine learning and artificial intelligence, an area where her extensive experience and expertise will be valuable," said Hanson. "We look forward to Sree's contributions as we continue to drive our strategic initiatives."
Kolli joined Align Technology in June 2003 and has held positions of increasing responsibility leading business operations and engineering for customer-facing applications during her tenure, according to a news release on the Zimmer Biomet website. She was promoted to vice president, information technology in December 2012 and to senior vice president, global information technology in February 2018.
Prior to joining Align Technology, she held technical lead positions with Citadon and Accenture. She is a member of the Executive Advisory Board at Salesforce.com and an external advisor on the Board of Trustees Committee on Information Technology at the University of San Francisco.
Kolli earned a master's degree in computer applications at the National Institute of Technology in Trichy, India, and is a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business in California.
On the retirement of Glasscock Hanson said, "Over the last 20 years, Larry has made tremendous contributions toward helping the company advance our mission and has played an essential role in the overall growth and transformation of our business. On behalf of the entire board of directors and leadership team, I want to extend my deep gratitude to Larry for his exemplary leadership and service as a member of Zimmer Biomet's board. We have all benefited immensely from Larry's guidance, leadership and mentorship as board chair."
Glasscock has been a member of the company's board of directors since its inception in 2001 and has served as non-executive chairman since May 2013. During his tenure as a director, he has also served as a member of the Audit, Corporate Governance, and Compensation and Management Development Committees and as chair of the Audit Committee. Glasscock is the retired chairman, president and chief executive officer of Anthem Inc.
On the appointment of Hanson as chairman of the board, Glasscock said, "Through his leadership during his three-year tenure as president and CEO, Bryan has transformed Zimmer Biomet into a stronger leader and innovator in the global medical technology space. I and the entire board of directors are excited to see how he continues to drive forward the company's mission and deliver even greater growth and value in his appointment as chairman of the board."
Begley has been a Zimmer Biomet board member since 2012 and currently serves as chairman of the Quality, Regulatory and Technology Committee and as a member of the Compensation and Management Development Committee. He is the retired chairman and chief executive officer of Hospira Inc. and currently serves as non-executive chairman of the board of Hanger Inc.
Hanson said, "We are fortunate to have an individual of the caliber of Chris' experience to serve as lead independent director. He is an accomplished business leader with vast healthcare industry and corporate governance experience. Chris provides valuable strategic perspective as a board member, and I look forward to working with him in his new role."
Boudreaux informed the board that she does not intend to stand for reelection at the upcoming 2021 annual meeting of shareholders. She has been a member of the board since 2012, currently serving on the Audit and Corporate Governance Committees. She is president and chief executive officer of Anthem Inc.
"The Board expresses its sincere gratitude to Gail for her many significant contributions and years of dedicated service to Zimmer Biomet and the company's shareholders," said Hanson.
For more information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
Those changes include:
• Sreelakshmi Kolli, senior vice president, chief digital officer of Align Technology Inc., has been appointed as a member of the board of directors, effective immediately.
• Zimmer Biomet Non-Executive Chairman Larry C. Glasscock will retire in May pursuant to the mandatory retirement age in the company's corporate governance guidelines.
• Zimmer Biomet President and CEO Bryan C. Hanson will be appointed as chairman of the board upon Glasscock's retirement.
• Christopher B. Begley will be named lead independent director.
• Gail K. Boudreaux has informed the board that she does not intend to stand for re-election at the upcoming 2021 annual meeting of shareholders.
"The addition of Sree to our board of directors comes at a time when Zimmer Biomet is expanding our portfolio of integrated digital and robotic technologies that leverage data, machine learning and artificial intelligence, an area where her extensive experience and expertise will be valuable," said Hanson. "We look forward to Sree's contributions as we continue to drive our strategic initiatives."
Kolli joined Align Technology in June 2003 and has held positions of increasing responsibility leading business operations and engineering for customer-facing applications during her tenure, according to a news release on the Zimmer Biomet website. She was promoted to vice president, information technology in December 2012 and to senior vice president, global information technology in February 2018.
Prior to joining Align Technology, she held technical lead positions with Citadon and Accenture. She is a member of the Executive Advisory Board at Salesforce.com and an external advisor on the Board of Trustees Committee on Information Technology at the University of San Francisco.
Kolli earned a master's degree in computer applications at the National Institute of Technology in Trichy, India, and is a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business in California.
On the retirement of Glasscock Hanson said, "Over the last 20 years, Larry has made tremendous contributions toward helping the company advance our mission and has played an essential role in the overall growth and transformation of our business. On behalf of the entire board of directors and leadership team, I want to extend my deep gratitude to Larry for his exemplary leadership and service as a member of Zimmer Biomet's board. We have all benefited immensely from Larry's guidance, leadership and mentorship as board chair."
Glasscock has been a member of the company's board of directors since its inception in 2001 and has served as non-executive chairman since May 2013. During his tenure as a director, he has also served as a member of the Audit, Corporate Governance, and Compensation and Management Development Committees and as chair of the Audit Committee. Glasscock is the retired chairman, president and chief executive officer of Anthem Inc.
On the appointment of Hanson as chairman of the board, Glasscock said, "Through his leadership during his three-year tenure as president and CEO, Bryan has transformed Zimmer Biomet into a stronger leader and innovator in the global medical technology space. I and the entire board of directors are excited to see how he continues to drive forward the company's mission and deliver even greater growth and value in his appointment as chairman of the board."
Begley has been a Zimmer Biomet board member since 2012 and currently serves as chairman of the Quality, Regulatory and Technology Committee and as a member of the Compensation and Management Development Committee. He is the retired chairman and chief executive officer of Hospira Inc. and currently serves as non-executive chairman of the board of Hanger Inc.
Hanson said, "We are fortunate to have an individual of the caliber of Chris' experience to serve as lead independent director. He is an accomplished business leader with vast healthcare industry and corporate governance experience. Chris provides valuable strategic perspective as a board member, and I look forward to working with him in his new role."
Boudreaux informed the board that she does not intend to stand for reelection at the upcoming 2021 annual meeting of shareholders. She has been a member of the board since 2012, currently serving on the Audit and Corporate Governance Committees. She is president and chief executive officer of Anthem Inc.
"The Board expresses its sincere gratitude to Gail for her many significant contributions and years of dedicated service to Zimmer Biomet and the company's shareholders," said Hanson.
For more information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
Have a news tip? Email [email protected] or Call/Text 360-922-3092